Page last updated: 2024-08-21

thiazoles and Bowel Diseases, Inflammatory

thiazoles has been researched along with Bowel Diseases, Inflammatory in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (38.46)18.2507
2000's2 (15.38)29.6817
2010's5 (38.46)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Marafini, I; Monteleone, G; Salvatori, S; Troncone, E1
Blumberg, RS; Cheng, M; Han, X; Huang, Z; Nie, Y; Ren, K; Ruan, HB; Sahu, C; Wu, K; Xiong, X; Xu, B; Zhao, M1
Song, SD; Tang, HF1
Choi, HG; Dančík, V; Gagnon, J; Graham, DB; Gray, NS; Hussain, MM; Khor, B; Narayan, K; O'Connell, DJ; Perez, JR; Reinecker, HC; Russell, CN; Schreiber, SL; Shamji, AF; Song, JH; Sundberg, TB; Xavier, RJ1
Procoli, F1
Bickston, SJ; Kappus, MR; Snider, KR1
Gotham, S1
Clay, MP; Hanssen, BR; Lindstrom, TD; Surapaneni, SS1
Furitsu, H; Iga, T; Kotaki, H; Sawada, Y; Yamada, H2
Bailey, ST; Flanigan, A; Jiang, W; Keilbaugh, SA; Lazar, MA; Murthy, S; Rangwala, SM; Su, CG; Wen, X; Wu, GD1
Cai, TQ; Gan, X; Wong, B; Wright, SD1

Reviews

3 review(s) available for thiazoles and Bowel Diseases, Inflammatory

ArticleYear
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases.
    Pharmacological research, 2020, Volume: 155

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Oligonucleotides; Phosphodiesterase 4 Inhibitors; Thalidomide; Thiazoles; Transforming Growth Factor beta

2020
[Progress in PDE4 targeted therapy for inflammatory diseases].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2014, Volume: 43, Issue:3

    Topics: Aminopyridines; Aminoquinolines; Arthritis; Asthma; Benzamides; Cyclopropanes; Dermatitis; Humans; Inflammation; Inflammatory Bowel Diseases; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Sulfones; Thalidomide; Thiazoles

2014
Tetomilast: new promise for phosphodiesterase-4 inhibitors?
    Expert opinion on investigational drugs, 2012, Volume: 21, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Humans; Inflammatory Bowel Diseases; Phosphodiesterase 4 Inhibitors; Thiazoles

2012

Other Studies

10 other study(ies) available for thiazoles and Bowel Diseases, Inflammatory

ArticleYear
Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation.
    EMBO molecular medicine, 2018, Volume: 10, Issue:8

    Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Colitis; Dysbiosis; Epithelial Cells; Fecal Microbiota Transplantation; Female; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; N-Acetylglucosaminyltransferases; Paneth Cells; Protein Processing, Post-Translational; Pyrans; STAT Transcription Factors; Thiazoles

2018
Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Aug-26, Volume: 111, Issue:34

    Topics: Aniline Compounds; Animals; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cytokines; Dasatinib; Dendritic Cells; Drug Evaluation, Preclinical; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-10; Intestine, Small; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Quinolines; Signal Transduction; T-Lymphocytes, Regulatory; Thiazoles; Transcription Factors

2014
Clinical trial on the efficacy of masitinib in canine IBD.
    The Veterinary record, 2010, Nov-06, Volume: 167, Issue:19

    Topics: Animals; Anti-Inflammatory Agents; Benzamides; Clinical Trials as Topic; Dog Diseases; Dogs; Inflammatory Bowel Diseases; Piperidines; Pyridines; Thiazoles; Treatment Outcome

2010
Digestive Disease Week 2004. Bowel inflammation.
    IDrugs : the investigational drugs journal, 2004, Volume: 7, Issue:6

    Topics: Azepines; Cholinergic Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Isoquinolines; Pyridazines; Tacrolimus; Thiazoles

2004
Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Chirality, 1999, Volume: 11, Issue:3

    Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Dogs; Female; Half-Life; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Microsomes, Liver; Phenols; Protein Binding; Rats; Rats, Inbred F344; Stereoisomerism; Sulfoxides; Thiazoles; Thiazolidines

1999
Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia.
    Biopharmaceutics & drug disposition, 1999, Volume: 20, Issue:2

    Topics: Animals; Benzothiazoles; Disease Models, Animal; Inflammatory Bowel Diseases; Inulin; Kidney Tubules, Proximal; Lipoxygenase Inhibitors; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Thromboxane-A Synthase; Uric Acid; Uricosuric Agents

1999
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
    The Journal of clinical investigation, 1999, Volume: 104, Issue:4

    Topics: Animals; Caco-2 Cells; Colitis; Cytokines; DNA-Binding Proteins; Epithelium; Gene Expression; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Ligands; Mice; Microbodies; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors

1999
E 3040.
    Drugs in R&D, 1999, Volume: 1, Issue:3

    Topics: Animals; Benzothiazoles; Colitis, Ulcerative; Drugs, Investigational; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Lipoxygenase Inhibitors; Pyridines; Rats; Thiazoles; Thromboxane-A Synthase

1999
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.
    Biopharmaceutics & drug disposition, 1999, Volume: 20, Issue:5

    Topics: Animals; Benzothiazoles; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred DBA; Pyrazinamide; Pyridines; Thiazoles; Uric Acid; Uricosuric Agents

1999
Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli.
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2001, Volume: 21, Issue:2

    Topics: Caco-2 Cells; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-1; Lipopolysaccharides; Matrix Metalloproteinase 9; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation

2001